Live Salesforce, Inc. Vote →

Never Miss Important Company Updates Again

Get AI-powered summaries of SEC filings delivered to your inbox

Follow your favorite stocks and get email alerts when they release important updates. Completely free.

Covers 5,000+ public companies
Get started
Sign up to stay up to date with the stocks you care about
Follow Fractyl Health, Inc.

Get SEC filing alerts via email and in your feed for Fractyl Health, Inc.

GUTS

Fractyl Health, Inc.

About Fractyl Health, Inc.

Fractyl Health develops innovative, disease-modifying therapies targeting the gut and pancreas to treat obesity and type 2 diabetes. Its lead products, Revita and Rejuva, aim to provide durable weight management and metabolic remission through procedural and gene therapy approaches. Focused on long-term benefits, the company targets large markets with solutions designed to address root causes, reduce treatment burden, and shift care from symptom management to disease elimination.
This description was generated via AI from an annual report. Updated 8 months ago.

Latest SEC Filings from Fractyl Health, Inc.

1
1
2
1
3
1
4
1
5
1
6
1
7
1